{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:25:13Z","timestamp":1765887913009},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"The Ministry of Health, Labour and Welfare (MHLW)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development (AMED)","doi-asserted-by":"publisher","award":["16ak0101010j0105","17fk0108124j0101"],"award-info":[{"award-number":["16ak0101010j0105","17fk0108124j0101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biologicals.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:15:59Z","timestamp":1504224959000},"page":"100-108","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of marker gene expression as a potential predictive marker of leukopenic toxicity for inactivated influenza vaccines"],"prefix":"10.1016","volume":"50","author":[{"given":"Eita","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Momose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hiradate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Furuhata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Kamachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken J.","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2017.08.003_bib1","series-title":"Minimum requirements for biological products","author":"National Institute of Infectious Diseases","year":"2006"},{"key":"10.1016\/j.biologicals.2017.08.003_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7883\/yoken1952.28.37","article-title":"Toxicities of influenza vaccine: peripheral leukocytic response to live and inactivated influenza viruses in mice","volume":"1","author":"Kurokawa","year":"1975","journal-title":"Jpn J Med Sci Biol"},{"key":"10.1016\/j.biologicals.2017.08.003_bib3","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.vaccine.2008.02.031","article-title":"Application of DNA microarray technology to influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine safety evaluation","volume":"24","author":"Mizukami","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2017.08.003_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.vaccine.2016.12.036","article-title":"A\u00a0novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests","volume":"35","author":"Sasaki","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2017.08.003_bib5","doi-asserted-by":"crossref","first-page":"e101835","DOI":"10.1371\/journal.pone.0101835","article-title":"System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test","volume":"9","author":"Mizukami","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2017.08.003_bib6","doi-asserted-by":"crossref","first-page":"e0124392","DOI":"10.1371\/journal.pone.0124392","article-title":"Establishment of a new quality control and vaccine safety test for influenza vaccines and adjuvants using gene expression profiling","volume":"10","author":"Momose","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2017.08.003_bib7","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1073\/pnas.1319268111","article-title":"Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist","volume":"111","author":"Kobiyama","year":"2014","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.biologicals.2017.08.003_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4161\/hv.22950","article-title":"TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36\/AHG malaria vaccine in nonhuman primate models","volume":"9","author":"Tougan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.biologicals.2017.08.003_bib9","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(03)15014-3","article-title":"Safety and antigenicity of whole virus and subunit influenza A\/Hong Kong\/1073\/99 (H9N2) vaccine in healthy adults: phase I randomised trial","volume":"362","author":"Stephenson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2017.08.003_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virusres.2004.02.029","article-title":"Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use","volume":"103","author":"Hehme","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.biologicals.2017.08.003_bib11","author":"WHO"},{"key":"10.1016\/j.biologicals.2017.08.003_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrmicro979","article-title":"From lethal virus to life-saving vaccine development inactivated vaccines for pandemic influenza","volume":"2","author":"Wood","year":"2004","journal-title":"Nat Rev Microb"},{"key":"10.1016\/j.biologicals.2017.08.003_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/4401099a","article-title":"Flu-vaccine makers toil to boost supply","volume":"440","author":"Dennis","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2017.08.003_bib14","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.vaccine.2013.02.016","article-title":"Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-\u03b1-dependent apoptosis","volume":"31","author":"Ato","year":"2013","journal-title":"Vaccine"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105617300982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105617300982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T10:11:48Z","timestamp":1617012708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105617300982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":14,"alternative-id":["S1045105617300982"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2017.08.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of marker gene expression as a potential predictive marker of leukopenic toxicity for inactivated influenza vaccines","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}